From November 28, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on November 30, 2023.
Chemclin Diagnostics Co., Ltd.
Equities
688468
CNE100005311
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.7 CNY | -0.89% | +1.98% | -37.91% |
05-21 | Shareholders to Cut Up to 2% Stake in Chemclin Diagnostics | MT |
05-03 | Chemclin Diagnostics Launches Homegrown Immunodetection Kits | MT |
1st Jan change | Capi. | |
---|---|---|
-37.91% | 365M | |
-9.74% | 11.48B | |
-9.80% | 7.64B | |
+27.84% | 5.49B | |
-15.47% | 3.86B | |
+8.47% | 2.61B | |
-63.81% | 2.42B | |
-9.24% | 2.27B | |
+21.21% | 2.1B | |
-9.38% | 1.76B |
- Stock Market
- Equities
- 688468 Stock
- News Chemclin Diagnostics Co., Ltd.
- Tranche Update on Chemclin Diagnostics Co., Ltd.'s Equity Buyback Plan announced on November 30, 2023.